Home / Pharmaceutical company intelligence
Medera Pharmaceuticals (Pvt) Ltd logo
Pharmaceutical company intelligence

Medera Pharmaceuticals (Pvt) Ltd

Private pharmaceutical manufacturer · Rawat · Pakistan

Islamabad/Rawat pharmaceutical manufacturer established in the early 2000s with tablets, capsules, liquids, semisolids and injectable production.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation23 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date27 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Legal / official name
Medera Pharmaceuticals (Pvt.) Ltd.
Company type
Private pharmaceutical manufacturer
Address
Plot No. 2, Street N-4, National Industrial Zone, Rawat, Islamabad, Pakistan
Phone
+92 51 4499190; +92 345 8555946
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000501 Medera Pharmaceuticals (Pvt) Ltd. · Islamabad
Formulation 000714 Medera Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000714 91 linked products · source seen 23 Sep 2026 View source ↗
Corporate profile source ledger Logo Url source ↗ Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx90public portfolio records represented
REG78unique registrations represented
IDX56indexed MedInfoBase presentations
SRC0additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR90current validated price records
G47generic molecules in indexed catalogue
DF7dosage-form groups
TA6therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage100%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage96%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixMedera Pharmaceuticals (Pvt) LtdShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medera-pharmaceuticals-pvt-ltdGenerated 24 Sep 2026Anti-infectives57 · 63%CNS & mental health16 · 18%Cardiovascular7 · 8%Vitamins, minerals & nutrition5 · 6%Gastrointestinal & hepatology3 · 3%Dermatology2 · 2%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioMedera Pharmaceuticals (Pvt) LtdDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medera-pharmaceuticals-pvt-ltdGenerated 24 Sep 202690presentationsTablet35 · 39%Injection16 · 18%Capsule13 · 14%Suspension12 · 13%Cream8 · 9%Gel3 · 3%Other forms3 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionMedera Pharmaceuticals (Pvt) LtdCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medera-pharmaceuticals-pvt-ltdGenerated 24 Sep 202686comparable productsBelow peer median16 · 19%Near peer median42 · 49%Above peer median28 · 33%Company median price position+2.1%Lowest-price equivalents5Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsMedera Pharmaceuticals (Pvt) LtdCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/medera-pharmaceuticals-pvt-ltdGenerated 24 Sep 2026Nabiqasim Industries (Pvt) Ltd.,31 shared66% overlapCCL Pharmaceuticals (Pvt.) Limited29 shared62% overlapBio-Labs(Pvt) Ltd28 shared60% overlapValor Pharmaceuticals28 shared60% overlapPharmasol (Pvt) Ltd.26 shared55% overlapCRYSTOLITE PHARMACEUTICALS26 shared55% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives57 products · 63%
CNS & mental health16 products · 18%
Cardiovascular7 products · 8%
Vitamins, minerals & nutrition5 products · 6%
Gastrointestinal & hepatology3 products · 3%
Dermatology2 products · 2%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Antipsychotics12 products · 13%
Antifungals8 products · 9%
Third-generation cephalosporins7 products · 8%
Macrolide antibacterials7 products · 8%
Fluoroquinolone antibacterials7 products · 8%
Antivirals6 products · 7%
Vitamins / minerals / hematinics5 products · 6%
Lincosamide antibacterials4 products · 4%
Formulation footprint

Dosage forms

Tablet35 products
Injection16 products
Capsule13 products
Suspension12 products
Cream8 products
Gel3 products
Lotion3 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 OlentineOlanzapine + Fluoxetine 5presentations 25 mg + 3 mg, 25 mg + 6 mg, 3 mg + 25 mg, 6 mg + 25 mg · Capsule #2 AvecareCeftriaxone 4presentations 1 g, 250 mg, 500 mg · Injection #3 AzinalAzithromycin 4presentations 200 mg/5 mL, 250 mg, 500 mg · Suspension, Capsule #4 RespimedRisperidone 4presentations 1 mg, 2 mg, 3 mg, 4 mg · Tablet #5 ViromedEntecavir 4presentations 0.5 mg · Tablet #6 AvecefCefixime 3presentations 100 mg/5 mL, 200 mg/5 mL, 400 mg · Suspension, Capsule
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1619% of comparable products
Near market median42within ±5% of median
Above market median2833% of comparable products
Lowest-price equivalents5ties included
Company median price position +2.1% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Omicent 20 mgOmeprazole · Injection · 14's PKR 16.52/vial/unit-95.4% vs market median Omicent 40 mgOmeprazole · Injection · 14's PKR 36.88/vial/unit-93.4% vs market median Cip-Era 250 Dry Susp 250 mg/5 mLCiprofloxacin · Dry suspension · 60ml PKR 3.30/mL-35.0% vs market median Medchloro 250 mgChloroquine · Tablet · 500's PKR 1.24/tablet-20.8% vs market median Medvasc 5 mgAmlodipine · Tablet · 20's PKR 8.92/tablet-17.7% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Nabiqasim Industries (Pvt) Ltd.,365 products · 118 generics 31shared generics CCL Pharmaceuticals (Pvt.) Limited249 products · 99 generics 29shared generics Bio-Labs(Pvt) Ltd236 products · 82 generics 28shared generics Valor Pharmaceuticals219 products · 97 generics 28shared generics Pharmasol (Pvt) Ltd.257 products · 102 generics 26shared generics CRYSTOLITE PHARMACEUTICALS130 products · 70 generics 26shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers78Distinct registrations among indexed, published, presentation-validated products only
Verified price observations90
Products with a verified price90
Products with multiple price observations0
Source records with multiple versions89
Latest portfolio source check22 Sep 2026
Latest effective price date27 Jul 2026
Latest source observation23 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

78 unique registration(s) · 56 indexed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Intelligence filter: Therapeutic areaAnti-infectives Clear intelligence filters
Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Avecare Ceftriaxone 500 mg IM injection 1's 086143 PKR 336.92 PKR 336.92/vial/unit Near median
Avecare Ceftriaxone 500 mg IV injection 1's 086144 PKR 336.92 PKR 336.92/vial/unit 7% above median
Avecare Ceftriaxone 1 g Injection 1's 086145 PKR 636.18 PKR 636.18/vial/unit 6% above median
Avecare Ceftriaxone 250 mg Injection 1's 087390 PKR 196.09 PKR 196.09/vial/unit Near median
Avecef Cefixime 400 mg Capsule 5's 087391 PKR 592.03 PKR 118.41/capsule Near median
Avecef Cefixime 100 mg/5 mL Dry suspension 30ml 087392 PKR 330.39 PKR 11.01/mL 5% above median
Avecef Cefixime 200 mg/5 mL Dry suspension 30ml 087393 PKR 404.33 PKR 13.48/mL Near median
Azcin Azithromycin 500 mg Tablet 6's 106145 PKR 441.57 PKR 73.60/tablet 13% below median
Azcin Azithromycin 250 mg Tablet 6's 106146 PKR 240.86 PKR 40.14/tablet 15% below median
Azinal Azithromycin 500 mg Capsule 3's 073020 PKR 247.73 PKR 82.58/capsule Near median
Azinal Azithromycin 200 mg/5 mL Dry suspension 30ml 073021 PKR 603.35 PKR 20.11/mL 5% below median
Azinal Azithromycin 250 mg Capsule 6's 116369 PKR 305.19 PKR 50.87/capsule Near median
Azinal Azithromycin 250 mg Capsule 10's 116369 PKR 508.64 PKR 50.86/capsule Near median
Cip-Era Ciprofloxacin 125 mg/5 mL Dry suspension 60ml 072718 PKR 222.36 PKR 3.71/mL Near median
Cip-Era 250 Dry Susp Ciprofloxacin 250 mg/5 mL Dry suspension 60ml 072719 PKR 198.19 PKR 3.30/mL 35% below median
Cip-Era-250 Ciprofloxacin 250 mg Tablet 10’S 072713 PKR 257.65 PKR 25.77/tablet Near median
Cip-Era-500 Ciprofloxacin 500 mg Tablet 10’S 072714 PKR 426.10 PKR 42.61/tablet Near median
Clarimed 125 Dry Sus Clarithromycin 125 mg/5 mL Dry suspension 60ml 073022 PKR 441.96 PKR 7.37/mL Near median
Climed Clindamycin 2% Cream 40gm 072702 PKR 568.80 PKR 14.22/g 13% above median
Climed Clindamycin 1 % Gel 10gm 111036 PKR 172.58 PKR 17.26/g 64% below median
Climed Plus Clindamycin + Benzoyl peroxide 1% + 5% Gel 10gm 111037 PKR 396.93 PKR 39.69/g No comparator
Climed-T Clindamycin 10 mg/mL Lotion 30ml 115341 PKR 216.16 PKR 7.21/mL Near median
Clomicort H Clotrimazole 1 % Cream 10gm 113780 PKR 123.92 PKR 12.39/g 100% above median
Clovimed Aciclovir 5 % Cream 10gm 116351 PKR 392.81 PKR 39.28/g 13% above median
Eravanco Vancomycin 1 g Injection 1's 110991 PKR 1,950.13 PKR 1,950.13/vial/unit Near median
Eravanco Vancomycin 500 mg Injection 1's 110992 PKR 1,208.05 PKR 1,208.05/vial/unit Near median
Fantar-40 Artemether + Lumefantrine 40 mg + 240 mg Tablet 8's 075349 PKR 523.21 PKR 65.40/tablet Near median
Fantar-80 Artemether + Lumefantrine 80 mg + 480 mg Tablet 6's 075433 PKR 654.03 PKR 109.01/tablet Near median
Fosemed Fosfomycin 250 mg Dry suspension 60ml 073025 PKR 178.37 PKR 2.97/mL No comparator
Fungimed Fluconazole 50 mg/5 mL Dry suspension 35ml 073024 PKR 416.20 PKR 11.89/mL Near median
Levor-250 Levofloxacin 250 mg Tablet 10’S 072711 PKR 495.46 PKR 49.55/tablet Near median
Levor-500 Levofloxacin 500 mg Tablet 10’S 072712 PKR 824.46 PKR 82.45/tablet Near median
Linzid Linezolid 600 mg Tablet 12’S 072715 PKR 5,065.69 PKR 422.14/tablet 7% above median
Linzid Linezolid 100 mg/5 mL Suspension 60ml 072717 PKR 693.66 PKR 11.56/mL 5% above median
Linzid Linezolid 100 mg/5 mL Suspension 120ml 072717 PKR 1,317.96 PKR 10.98/mL Near median
Medchloro Chloroquine 250 mg Tablet 500's 102283 PKR 619.81 PKR 1.24/tablet 21% below median
Medropenum Meropenem 500 mg IV injection 1's 113918 PKR 2,209.88 PKR 2,209.88/vial/unit 6% above median
Medropenum Meropenem 1 g Injection 1's 113919 PKR 4,130.61 PKR 4,130.61/vial/unit 6% above median
Merospect Imipenem + Cilastatin 500 mg + 500 mg IV injection 1's 113920 PKR 1,548.98 PKR 1,548.98/vial/unit Near median
Methrin Permethrin 5% Cream 30gm 072705 PKR 122.76 PKR 4.09/g Near median
MiCool Oral Miconazole 2 % Gel 20gm 073008 PKR 177.54 PKR 8.88/g 5% above median
MiCool-H Miconazole + Hydrocortisone 2% + 1% Cream 10gm 073011 PKR 103.05 PKR 10.31/g 6% above median
Mosqonil Artemether + Lumefantrine 15 mg + 90 mg/5 mL Dry suspension 60ml 072720 PKR 356.74 PKR 5.95/mL Near median
Moxider Moxifloxacin 400 mg Tablet 5's 105012 PKR 762.72 PKR 152.54/tablet 17% below median
N-Scab Permethrin 5% Lotion 60ml 073190 PKR 158.55 PKR 2.64/mL Near median
Ritora 200/ Lopinavir + Ritonavir Lopinavir + Ritonavir 200 mg + 50 mg Tablet 120's 106144 PKR 12,331.98 PKR 102.77/tablet 7% above median
Tazonem Piperacillin + tazobactam 4 g + 0.5 g Injection 1's 087359 PKR 1,359.04 PKR 1,359.04/vial/unit 12% below median
Tazonem Piperacillin + tazobactam 2 g + 250 mg Injection 1's 087360 PKR 660.10 PKR 660.10/vial/unit 12% above median
Terbimed Terbinafine 125 mg Tablet 10's 092165 PKR 607.68 PKR 60.77/tablet 17% above median
Terbimed Terbinafine 250 mg Tablet 10's 113965 PKR 1,032.65 PKR 103.27/tablet 27% above median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Medera Pharmaceuticals (Pvt) Ltd — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 24, 2026, from https://medinfobase.com/company/medera-pharmaceuticals-pvt-ltd/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.